summary of conclusions
Download
Skip this Video
Download Presentation
Summary of Conclusions

Loading in 2 Seconds...

play fullscreen
1 / 5

Summary of Conclusions - PowerPoint PPT Presentation


  • 205 Views
  • Uploaded on

Summary of Conclusions. Expert Meeting on a High-Level ACT Subsidy January 18-19, 2007. Main Agreements from Day 1. Vital and urgent need to increase access to ACTs to slow growing drug resistance and rising malaria deaths Broad support for a high-level buyer subsidy

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Summary of Conclusions' - ryanadan


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
summary of conclusions

Summary of Conclusions

Expert Meeting on a High-Level ACT Subsidy

January 18-19, 2007

main agreements from day 1
Main Agreements from Day 1
  • Vital andurgent need to increase access to ACTs to slow growing drug resistance and rising malaria deaths
  • Broad support for a high-level buyer subsidy
  • Confidence that the technical issues can be overcome
  • Agreement that the most appropriate partners will be engaged
many issues were raised yesterday
Many issues were raised yesterday
  • Additional health interventions
  • Actors and partners
  • Incentives for suppliers and distributors
  • End-product vs. component subsidy
  • National regulatory issues
  • Formal vs. informal sector
  • Tariffs and taxes
  • Big-bang vs. phased entry
  • End-user prices
  • Patient and provider behavior
  • Product selection and availability
  • Home-based management
  • Drug resistance
  • Data for monitoring
  • Eligibility of producers
  • Compliance
  • Sustainability
  • Accountability
  • Premium vs. non-premium
  • Effective promotion of generic drugs
  • Quality of drugs
  • Local needs
  • Predictability of demand
  • Conditionalities
  • Incentives for innovation
  • Market distortion
  • Demand forecasting
  • Local manufacturing
  • Equity
two types of issues

Subsidy-Design Tasks

Broader Systemic Issues

Two types of issues
  • Estimate required funding commitment and define subsidy levels/ex-factory price
  • Outline facility architecture and management
  • Develop communication strategy to promote uptake of ACTs
  • Plan for the responsible introduction of ACTs (monitoring of resistance, appropriate technical support, operational research, monitoring and evaluation, equity considerations, sustainability concerns)
  • Strengthen policies to promote quality assurance, pre-qualification, compliance and local manufacturing
  • Strengthen integrated national malaria control programs
  • Leverage community based programs and bolster home based management initiatives
  • Refine demand forecasting
  • Rationalize relevant national policies (e.g. taxes and tariffs, OTC access)
proposed timeline
Proposed Timeline
  • A steering committee will be formed
  • Roll-Back Malaria will convene the first meeting of the steering committee
  • Key dates:
    • First draft of report prepared by Dalberg by early March
    • Detailed plan finalized by Dalberg by June
    • Launch meeting in about November (in Sub-Saharan Africa)
ad